Thomas Flaten
Stock Analyst at Lake Street
(3.19)
# 1,094
Out of 5,150 analysts
36
Total ratings
42.11%
Success rate
5.58%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMDX Insight Molecular Diagnostics | Maintains: Buy | $8 → $12 | $5.45 | +120.18% | 1 | Feb 17, 2026 | |
| CSTL Castle Biosciences | Maintains: Buy | $35 → $52 | $27.57 | +88.61% | 7 | Jan 12, 2026 | |
| PTHS Pelthos Therapeutics | Initiates: Buy | $50 | $24.19 | +106.70% | 1 | Dec 3, 2025 | |
| CNTB Connect Biopharma Holdings | Initiates: Buy | $9 | $2.48 | +262.90% | 1 | Dec 1, 2025 | |
| MDXH MDxHealth | Maintains: Buy | $7 → $9 | $3.35 | +168.66% | 1 | Nov 13, 2025 | |
| EVAX Evaxion | Maintains: Buy | $6 → $11 | $3.12 | +252.56% | 3 | Oct 20, 2025 | |
| HROW Harrow | Maintains: Buy | $42 → $70 | $38.61 | +81.32% | 1 | Sep 29, 2025 | |
| DERM Journey Medical | Maintains: Buy | $9 → $13 | $7.81 | +66.45% | 2 | Aug 13, 2025 | |
| RPID Rapid Micro Biosystems | Initiates: Buy | $8 | $4.24 | +88.68% | 1 | Jul 28, 2025 | |
| DMAC DiaMedica Therapeutics | Maintains: Buy | $11 → $14 | $7.71 | +81.58% | 2 | Jul 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8 | $2.64 | +203.03% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $15.50 | +158.06% | 1 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $4.12 | +94.17% | 2 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $8.67 | +3.81% | 2 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $45 | $11.90 | +278.31% | 3 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $11 | $4.33 | +154.04% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $25 | $20.17 | +23.95% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $0.51 | +282,252.94% | 2 | Nov 17, 2022 |
Insight Molecular Diagnostics
Feb 17, 2026
Maintains: Buy
Price Target: $8 → $12
Current: $5.45
Upside: +120.18%
Castle Biosciences
Jan 12, 2026
Maintains: Buy
Price Target: $35 → $52
Current: $27.57
Upside: +88.61%
Pelthos Therapeutics
Dec 3, 2025
Initiates: Buy
Price Target: $50
Current: $24.19
Upside: +106.70%
Connect Biopharma Holdings
Dec 1, 2025
Initiates: Buy
Price Target: $9
Current: $2.48
Upside: +262.90%
MDxHealth
Nov 13, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $3.35
Upside: +168.66%
Evaxion
Oct 20, 2025
Maintains: Buy
Price Target: $6 → $11
Current: $3.12
Upside: +252.56%
Harrow
Sep 29, 2025
Maintains: Buy
Price Target: $42 → $70
Current: $38.61
Upside: +81.32%
Journey Medical
Aug 13, 2025
Maintains: Buy
Price Target: $9 → $13
Current: $7.81
Upside: +66.45%
Rapid Micro Biosystems
Jul 28, 2025
Initiates: Buy
Price Target: $8
Current: $4.24
Upside: +88.68%
DiaMedica Therapeutics
Jul 18, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $7.71
Upside: +81.58%
Jul 1, 2025
Initiates: Buy
Price Target: $8
Current: $2.64
Upside: +203.03%
May 14, 2025
Maintains: Buy
Price Target: $60 → $40
Current: $15.50
Upside: +158.06%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $4.12
Upside: +94.17%
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $8.67
Upside: +3.81%
Mar 12, 2024
Maintains: Buy
Price Target: $60 → $45
Current: $11.90
Upside: +278.31%
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $4.33
Upside: +154.04%
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $20.17
Upside: +23.95%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $0.51
Upside: +282,252.94%